DE69519924D1 - Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten - Google Patents

Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten

Info

Publication number: DE69519924D1
Authority: DE; Germany
Prior art keywords: preparation; methods; gammaglobuline; treating cancer; preparations containing
Prior art date: 1994-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69519924T

Other languages

English (en)

Other versions

DE69519924T2 (de

Inventor

Yehuda Shoenfeld

Pnina Fishman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ARP Biomed Ltd

Original Assignee

ARP Biomed Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-14

Filing date

1995-03-09

Publication date

2001-02-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69519924(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-09 Application filed by ARP Biomed Ltd filed Critical ARP Biomed Ltd

2001-02-22 Publication of DE69519924D1 publication Critical patent/DE69519924D1/de

2001-08-23 Application granted granted Critical

2001-08-23 Publication of DE69519924T2 publication Critical patent/DE69519924T2/de

2015-03-10 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE69519924T 1994-03-14 1995-03-09 Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten Expired - Lifetime DE69519924T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21236194A	1994-03-14	1994-03-14
US08/340,094 US5562902A (en)	1994-03-14	1994-11-15	Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
PCT/US1995/002910 WO1995024927A1 (en)	1994-03-14	1995-03-09	Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins

Publications (2)

Publication Number	Publication Date
DE69519924D1 true DE69519924D1 (de)	2001-02-22
DE69519924T2 DE69519924T2 (de)	2001-08-23

Family

ID=26907064

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69519924T Expired - Lifetime DE69519924T2 (de)	1994-03-14	1995-03-09	Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten

Country Status (20)

Country	Link
US (2)	US5562902A (de)
EP (1)	EP0750514B1 (de)
JP (2)	JP4004062B2 (de)
KR (1)	KR100352583B1 (de)
CN (1)	CN1089007C (de)
AT (1)	ATE198711T1 (de)
AU (1)	AU700751B2 (de)
BR (1)	BR9507067A (de)
CA (1)	CA2184269A1 (de)
DE (1)	DE69519924T2 (de)
DK (1)	DK0750514T3 (de)
ES (1)	ES2155519T3 (de)
FI (1)	FI114011B (de)
GR (1)	GR3035758T3 (de)
HK (1)	HK1014493A1 (de)
IL (1)	IL112963A (de)
NZ (1)	NZ282659A (de)
PT (1)	PT750514E (de)
TW (1)	TW418091B (de)
WO (1)	WO1995024927A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070166313A1 (en) *	1994-03-14	2007-07-19	Yehuda Shoenfeld	Administration of gamma globulins to treat cancer
US20080050390A1 (en) *	1994-03-14	2008-02-28	Yehuda Shoenfeld	Administration of gamma globulins to treat metastatic melanoma
CA2331738A1 (en)	1998-05-07	1999-11-11	Research Corporation Technologies, Inc.	Oral administration of immunoglobulins for treating autoimmune hearing loss
TWI248819B (en) *	1999-09-27	2006-02-11	Arp Biomed Ltd	Pharmaceutical composition containing IVIG for use in treating lymphoma
AU4079001A (en) *	2000-03-10	2001-09-17	Medinnova As	Composition for the treatment of heart failure
AT410637B (de) *	2001-06-01	2003-06-25	Igeneon Krebs Immuntherapie	Verwendung von polyklonalen immunglobulinen
US20050106136A1 (en)	2002-02-15	2005-05-19	Richard Brunner	7s immunoglobulin for treatment of choroidal neovascularisation
US20080031903A1 (en) *	2006-07-27	2008-02-07	Andrea Gambotto	Method of treating ocular infections
US20090053217A1 (en) *	2007-05-07	2009-02-26	Miri Blank	Human anti-VEGF polyclonal antibodies and uses thereof
US20110311557A1 (en) *	2009-02-11	2011-12-22	Martin Heath Bluth	Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) *	2020-09-04	2024-04-05	中国医学科学院输血研究所	注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) *	2021-07-13	2024-04-05	中国医学科学院放射医学研究所	毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4699783A (en) *	1983-03-11	1987-10-13	Terman David S	Products and methods for treatment of cancer
US4834975A (en) *	1984-05-25	1989-05-30	Genetics Corporation	Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) *	1986-02-25	1987-10-13	Center For Molecular Medicine & Immunology	Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) *	1999-09-27	2006-02-11	Arp Biomed Ltd	Pharmaceutical composition containing IVIG for use in treating lymphoma

1994
- 1994-11-15 US US08/340,094 patent/US5562902A/en not_active Expired - Lifetime
1995
- 1995-03-09 AT AT95912808T patent/ATE198711T1/de not_active IP Right Cessation
- 1995-03-09 ES ES95912808T patent/ES2155519T3/es not_active Expired - Lifetime
- 1995-03-09 DE DE69519924T patent/DE69519924T2/de not_active Expired - Lifetime
- 1995-03-09 JP JP52408195A patent/JP4004062B2/ja not_active Expired - Fee Related
- 1995-03-09 KR KR1019960705054A patent/KR100352583B1/ko not_active Expired - Fee Related
- 1995-03-09 CN CN95192080A patent/CN1089007C/zh not_active Expired - Fee Related
- 1995-03-09 PT PT95912808T patent/PT750514E/pt unknown
- 1995-03-09 EP EP95912808A patent/EP0750514B1/de not_active Expired - Lifetime
- 1995-03-09 WO PCT/US1995/002910 patent/WO1995024927A1/en active IP Right Grant
- 1995-03-09 CA CA002184269A patent/CA2184269A1/en not_active Abandoned
- 1995-03-09 AU AU19848/95A patent/AU700751B2/en not_active Ceased
- 1995-03-09 NZ NZ282659A patent/NZ282659A/en not_active IP Right Cessation
- 1995-03-09 DK DK95912808T patent/DK0750514T3/da active
- 1995-03-09 BR BR9507067A patent/BR9507067A/pt not_active Application Discontinuation
- 1995-03-12 IL IL11296395A patent/IL112963A/xx not_active IP Right Cessation
- 1995-03-13 TW TW084102356A patent/TW418091B/zh not_active IP Right Cessation
- 1995-06-07 US US08/487,803 patent/US5965130A/en not_active Expired - Fee Related
1996
- 1996-09-12 FI FI963598A patent/FI114011B/fi not_active IP Right Cessation
1998
- 1998-12-22 HK HK98114792A patent/HK1014493A1/xx not_active IP Right Cessation
2001
- 2001-04-17 GR GR20010400610T patent/GR3035758T3/el not_active IP Right Cessation
2007
- 2007-02-08 JP JP2007029855A patent/JP2007119493A/ja active Pending

Also Published As

Publication number	Publication date
FI963598L (fi)	1996-09-12
AU1984895A (en)	1995-10-03
CA2184269A1 (en)	1995-09-21
BR9507067A (pt)	1997-09-30
CN1089007C (zh)	2002-08-14
JP4004062B2 (ja)	2007-11-07
JPH09512791A (ja)	1997-12-22
FI114011B (fi)	2004-07-30
DE69519924T2 (de)	2001-08-23
CN1148343A (zh)	1997-04-23
EP0750514B1 (de)	2001-01-17
ATE198711T1 (de)	2001-02-15
US5965130A (en)	1999-10-12
NZ282659A (en)	1998-06-26
IL112963A (en)	2000-02-17
IL112963A0 (en)	1995-06-29
ES2155519T3 (es)	2001-05-16
JP2007119493A (ja)	2007-05-17
KR100352583B1 (ko)	2002-12-26
TW418091B (en)	2001-01-11
US5562902A (en)	1996-10-08
FI963598A0 (fi)	1996-09-12
PT750514E (pt)	2001-06-29
HK1014493A1 (en)	1999-09-30
WO1995024927A1 (en)	1995-09-21
GR3035758T3 (en)	2001-07-31
EP0750514A1 (de)	1997-01-02
DK0750514T3 (da)	2001-05-21
AU700751B2 (en)	1999-01-14

Publication	Publication Date	Title
MY112405A (en)	2001-06-30	Method of tumer treatment.
DE69519924D1 (de)	2001-02-22	Gammaglobuline enthaltende immunotherapeutische präparate für die behandlung von krebskrankheiten
ATE186219T1 (de)	1999-11-15	Kombination von antihormonale und bindende moleküle zur krebsbehandlung
ATE260666T1 (de)	2004-03-15	Zellulärer impfstoff und deren verwendung für die behandlung von malignen, soliden tumoren
DE3789082D1 (de)	1994-03-24	Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
Rytömaa et al.	1969	Chloroma regression induced by the granulocytic chalone
ATE120372T1 (de)	1995-04-15	Antikörper für die antilymphozyten- antikörpertherapie.
DE69738981D1 (de)	2008-10-23	Gereinigte zubereitungen von 10-propargyl-10-deazaaminopterin und verfahren zu ihrer verwendung in der tumorbehandlung
IL141550A0 (en)	2002-03-10	Methods and compositions for the prevention or treatment of cancer
DE60116075D1 (de)	2006-01-26	Behandlung von tumoren mit photodynamischer therapie
BR9808263A (pt)	2000-05-16	Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
DE60033540D1 (de)	2007-04-05	Verabreichung von gammaglobulinen zur behandlung von lymphomen
WO2002074756A3 (de)	2002-12-12	Urokinase-inhibitoren
ATE475710T1 (de)	2010-08-15	Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
RU2093219C1 (ru)	1997-10-20	Способ лечения рака пищевода
DE59009724D1 (de)	1995-11-02	Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
DE59506911D1 (de)	1999-10-28	Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
ATE345838T1 (de)	2006-12-15	Verfahren und mittel zur prävention, hemmung und therapie von krebserkrankungen
RU97114158A (ru)	1999-08-10	Способ лечения злокачественных опухолей

Legal Events

Date	Code	Title	Description
2002-02-07	8363	Opposition against the patent